Fundz

Proniras reported raising $6.93 Million in an initial SEC Form D filing, from an offering of $12.2 Million

PRIVATEDec 29, 2023$6.9M of $12.2M raised

Amount Raised

$6.93 Million

$6.93 Million sold, per SEC Form D (first sale Dec 15, 2023)

Round Type

Seed

SeattleBiotechnology

Quick answer

Proniras raised $6.93 Million in a Seed round, dated December 15, 2023. Proniras is based in Seattle, Washington, United States.

How much did Proniras raise?
Proniras raised $6.93 Million in a Seed round on December 15, 2023.
What does Proniras do?
Proniras Corporation is a clinical-stage biotechnology developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders.
Where is Proniras based and how big is it?
Proniras is based in Seattle, Washington, United States. Fundz records about 4 employees.
Who are the decision-makers at Proniras?
Fundz holds 2 contacts at Proniras, including the Executive Officer, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Proniras that raised within 45 days of this round, from Fundz verified event records.

  • UniFAHS raised $1.4M (Seed) on January 29, 2024.
  • Biomakers raised $2.4M (Seed) on January 26, 2024.
  • Attralus raised $56M on January 26, 2024.
  • Aspira Women’s Health raised $6.5M on January 26, 2024.
  • RenovoRx raised $6.1M on January 26, 2024.
  • Calidi Biotherapeutics raised $1M on January 26, 2024.

Who to call at Proniras, and when

A new round usually means Proniras is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Proniras raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Proniras, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Proniras. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Proniras

Location

2815 EASTLAKE AVENUE EAST, SUITE 300

Seattle, Washington, United States

About

Proniras Corporation is a clinical-stage biotechnology developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders. The Company’s lead program PRN-001-01 (tezampanel) is being clinical developed as a treatment option for opioid withdrawal and related disorders of addiction. Although effective treatments exist for opioid addiction, painful and difficult withdrawal is one of the primary reasons why current treatment fails, and relapse occurs. By alleviating the symptoms associated with opioid withdrawal, Proniras hopes to help patients successfully discontinue opioid usage and sustain an opioid-free life. Proniras was formed in 2017 by Accelerator Life Science Partners.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Proniras raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsChristopher T., Executive Officer, Promoter hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Proniras's next move

See what Strategic adds

Proniras raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.